Home » Topics » BioWorld Science

BioWorld Science
RSS

Synblia Therapeutics patents PTPN11 inhibitors

Oct. 14, 2019

Evaluating the role of UCK2 as a biomarker for patient selection for RX-3117 treatment

Oct. 14, 2019

Novel phenylpropanoid analogue promotes neurogenesis, ameliorates cognitive impairment in AD models

Oct. 14, 2019

Mitochondrial mutations hamper nuclear DNA repair

Oct. 14, 2019

Better late than never for schizophrenia gene targeting

Oct. 14, 2019

[177Lu]PSMA-R2 shows strong antitumor activity in prostate cancer xenograft model

Oct. 14, 2019

Well Marker Bio describes new macrophage-stimulating protein receptor inhibitors

Oct. 14, 2019

Emory University discloses CXCR-4 and/or CCR5 antagonists

Oct. 14, 2019

New insulin receptor partial agonists discovered at Merck & Co.

Oct. 14, 2019

ABCC3 as a novel pharmacological target in pancreatic cancer

Oct. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...